REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 16th, 2017 • Bioptix, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 16th, 2017 Company IndustryTHIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of _________ 2017, among Bioptix, Inc., a Colorado corporation (the "Company"), and each signatory hereto (each, an "Investor" and collectively, the "Investors"). Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Purchase Agreement (as defined below).
FORM OF COMMON STOCK PURCHASE WARRANTBioptix, Inc. • March 16th, 2017 • In vitro & in vivo diagnostic substances
Company FiledMarch 16th, 2017 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [______] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six month anniversary of the Initial Issuance Date (the "Initial Exercise Date") and on or prior to the close of business on the thirty six (36) month anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from BIOPTIX, INC., a Colorado corporation (the "Company"), up to [____] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 16th, 2017 • Bioptix, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this "Agreement") is dated as of __, 2017, between Bioptix, Inc., a Colorado corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a "Purchaser" and collectively, the "Purchasers").
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • March 16th, 2017 • Bioptix, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionThis ESCROW DEPOSIT AGREEMENT (this "Agreement") dated as of this [__] day of March 2017 by and among BIOPTIX, INC., a Colorado corporation (the "Company"), having an address at 1775 38th Street, Boulder, CO 80301, [__] (the "Lead Investor") and CORPORATE STOCK TRANSFER, INC. (the "Escrow Agent"), a stock transfer agent, having an office at 3200 Cherry Creek South Drive, Suite 430, Denver, CO 80209. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Securities Purchase Agreement, dated [___], 2017 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the "Purchase Agreement").
ESCROW DEPOSIT AGREEMENTEscrow Deposit Agreement • March 16th, 2017 • Bioptix, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionThis ESCROW DEPOSIT AGREEMENT (this "Agreement") dated as of this [__] day of March 2017 by and among BIOPTIX, INC., a Colorado corporation (the "Company"), having an address at 1775 38th Street, Boulder, CO 80301, [__] (the "Lead Investor") and SIGNATURE BANK (the "Escrow Agent"), a New York State chartered bank, having an office at 950 Third Avenue, 9th Floor. New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Securities Purchase Agreement, dated March ____, 2017 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the "Purchase Agreement").